SCHEMBL4980914

SCHEMBL4980914

COc1ccc(C(=O)N2CCc3[c]nc(C(N)=O)nc3C2)c(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 2/20 0.49
HCRTR2 O43614 6/20 0.42
HCRTR1 O43613 5/20 0.42
HTT P42858 3/20 0.42
TSHR P16473 2/20 0.42
HSD11B1 P28845 1/20 0.41
LMNA P02545 4/20 0.40
USP2 O75604 1/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
GFER P55789 1/20 0.40
HPGD P15428 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4988101 0.87 HTT (0.46) HCRTR2HCRTR1HTTTSHRUSP2
SCHEMBL4989543 0.85 HPGD (0.45) ALDH1A1L3MBTL1POLBGAAHPGD
SCHEMBL4985375 0.83 GRM5 (0.51) ALDH1A1L3MBTL1HPGD
SCHEMBL4989388 0.83 MAPK1 (0.55) HTTLMNAMAPTKDM4EALDH1A1
SCHEMBL4986952 0.83 ALDH1A1 (0.43) TSHRMAPTKDM4EALDH1A1GAA
SCHEMBL4988720 0.82 HSD17B10 (0.41) TSHRMAPTKDM4EALDH1A1GFER
SCHEMBL4992436 0.81 MAPK1 (0.47) HTTLMNAMAPTKDM4EALDH1A1
SCHEMBL4985162 0.80 KDM4E (0.49) TSHRKDM4EALDH1A1POLBGAA
SCHEMBL4992491 0.79 MAPT (0.40) HTTLMNAMAPTKDM4EALDH1A1
SCHEMBL4990959 0.78 SMN1; SMN2 (0.50) LMNAMAPTALDH1A1L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed
US-7297700-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2007-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 HSP90AB1 1175/4885HCRTR2 334/4885HCRTR1 321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.